IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal of Psychopharmacology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

5.73

h-Index

2024-2025

 143

Rank

2024-2025

 1896

SJR

2024-2025

 1.708

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Journal of Psychopharmacology
Abbreviation J. Psychopharmacol.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)
h-index 143
Overall Rank/Ranking 1896
SCImago Journal Rank (SJR) 1.708
Impact Score 5.73
Publisher SAGE Publications Ltd
Country United Kingdom
ISSN 14617285, 02698811
Best Quartile Q1
Coverage History 1987-2025




Aim and Scope


The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.


About Journal of Psychopharmacology


Journal of Psychopharmacology is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by SAGE Publications Ltd. The overall rank of Journal of Psychopharmacology is 1896. According to SCImago Journal Rank (SJR), this journal is ranked 1.708. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 143. The best quartile for this journal is Q1.

The ISSN of Journal of Psychopharmacology journal is 14617285, 02698811. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Psychopharmacology is cited by a total of 2170 articles during the last 3 years (Preceding 2024).


Journal of Psychopharmacology Impact IF 2024-2025


The Impact IF 2024 of Journal of Psychopharmacology is 5.73, which is computed in 2025 as per its definition. Journal of Psychopharmacology IF is increased by a factor of 1.16 and approximate percentage change is 25.38% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Psychopharmacology Impact IF 2025 Prediction


Impact IF 2024 of Journal of Psychopharmacology is 5.73. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Journal of Psychopharmacology. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 5.73
2023 4.57
2022 3.87
2021 3.88
2020 3.57
2019 3.26
2018 4.01
2017 4.53
2016 4.65
2015 3.95
2014 4.35

Journal of Psychopharmacology h-index


  Table Setting

Journal of Psychopharmacology has an h-index of 143. It means 143 articles of this journal have more than 143 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Psychopharmacology ISSN


The ISSN of Journal of Psychopharmacology is 14617285, 02698811. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Psychopharmacology Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Psychopharmacology is 1896. According to SCImago Journal Rank (SJR), this journal is ranked 1.708. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Journal of Psychopharmacology by Year


Year SJR
2025/2026 Coming Soon
2024 1.708
2023 1.366
2022 1.120
2021 1.014
2020 1.333
2019 1.342
2018 1.672
2017 1.939
2016 2.095
2015 1.775
2014 1.659

Ranking of Journal of Psychopharmacology by Year


Year Ranking
2025/2026 Coming Soon
2024 1896
2023 2620
2022 3487
2021 4014
2020 2747
2019 2710
2018 1873
2017 1459
2016 1270
2015 1790
2014 1948

Journal of Psychopharmacology Publisher


Table Setting

Journal of Psychopharmacology is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1987-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Psychopharmacology is J. Psychopharmacol.. This abbreviation ('J. Psychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Psychopharmacology


If your research field is/are related to Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Journal of Psychopharmacology?

Journal of Psychopharmacology latest impact IF is 5.73. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 5.73 (2024) and 3.26 (2019), respectively, in the last 11 years. Moreover, its average IS is 4.22 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Journal of Psychopharmacology?

The Journal of Psychopharmacology has an SJR (SCImago Journal Rank) of 1.708, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.095 in 2016 and the lowest being 1.014 in 2021. Furthermore, the average SJR of the Journal of Psychopharmacology over the previous 11-year period stands at 4.22.


What's the latest h-index of the Journal of Psychopharmacology?

The latest h-index of the Journal of Psychopharmacology is 143.


Who's the publisher of the Journal of Psychopharmacology?

The Journal of Psychopharmacology is published by the SAGE Publications Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Journal of Psychopharmacology?

The Journal of Psychopharmacology is currently ranked 1896 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1270 in 2016 and its lowest position of 4014 in 2021.


What's the abbreviation or short name for the Journal of Psychopharmacology?

The standard ISO4 abbreviation for the Journal of Psychopharmacology is J. Psychopharmacol..


Is the "Journal of Psychopharmacology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Journal of Psychopharmacology is classified as a journal that the SAGE Publications Ltd publishes.


What's the scope or major areas of the Journal of Psychopharmacology?

The Journal of Psychopharmacology encompasses the following areas:

  • Medicine (miscellaneous)
  • Pharmacology
  • Pharmacology (medical)
  • Psychiatry and Mental Health

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Journal of Psychopharmacology?

The Journal of Psychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 14617285, 02698811.


What's the best quartile of the Journal of Psychopharmacology?

The best quartile for the Journal of Psychopharmacology is Q1 (2024).


What's the coverage history of the Journal of Psychopharmacology?

The Journal of Psychopharmacology coverage history can be summarized as follows: 1987-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Clinical Medicine and Research journal 14921 Marshfield Clinic 64 1.25
Criminal Justice Review journal 10284 SAGE Publications Inc. 46 1.91
International Journal of Mathematical Education in Science and Technology journal 6477 Taylor and Francis Ltd. 45 1.82
Abacus journal 11890 Wiley-Blackwell Publishing Ltd 56 2.95
Sex Education journal 6348 Routledge 51 2.49
Journal of Sociolinguistics journal 4415 Wiley-Blackwell Publishing Ltd 68 2.14
Transnational Corporations journal 13970 UNCTAD United Nations Conference on Trade and Development 30 1.63
Educational Measurement: Issues and Practice journal 6760 Wiley-Blackwell Publishing Ltd 68 1.54
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29

Check complete list




Year wise Impact Score (IS) of Journal of Psychopharmacology

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 5.73
2023 4.57
2022 3.87
2021 3.88
2020 3.57
2019 3.26
2018 4.01
2017 4.53
2016 4.65
2015 3.95
2014 4.35



Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

Lancet Psychiatry,The
Elsevier Ltd | United Kingdom

Clinical Psychology Review
Elsevier Inc. | United States

JAMA Psychiatry
American Medical Association | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Lancet Healthy Longevity, The
Elsevier Ltd | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Health Psychology Review
Routledge | United Kingdom

Molecular Psychiatry
Springer Nature | United Kingdom

See All